Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HECW2 antisense RNA 1 (HECW2-AS1) is a long non-coding RNA gene found in humans that is transcribed from the DNA strand opposite HECW2. Unlike its sense counterpart (HECW2, which encodes an E3 ubiquitin ligase protein), HECW2-AS1 does not encode a protein and functions—if any—have not been conclusively determined or validated. Current gene and disease association databases do not indicate a clear role for HECW2-AS1 in human health or disease, nor has it been established as a therapeutic drug target[2]. Information about its expression pattern, biological processes, or involvement in disease remains lacking or uncharacterized in current scientific databases and publications. If you are seeking information about the E3 ubiquitin ligase protein "HECW2", refer to that target specifically; "HECW2-AS1" only refers to the non-coding RNA, which is not currently an established therapeutic target[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HECW2 antisense RNA 1 (HECW2-AS1).